Exposure to drinking water disinfection by -products ( DBPs ) , such as trihalomethanes ( THMs ) , has been associated with bladder and colorectal cancer in humans. Exposure to DBPs has typically been determined by examining historical water treatment records and reconstructing study participants' water consumption histories. However, other exposure routes, such as dermal absorption and inhalation, may be important components of an individual's total exposure to drinking water DBPs. In this study, we examined individuals' exposure to THMs through drinking, showering, or bathing in tap water. Thirty -one adult volunteers showered with tap water for 10 min ( n = 11 ) , bathed for 10 min in a bathtub filled with tap water ( n = 10 ) , or drank 1 l of tap water during a 10 -min time period ( n = 10 ) . Participants provided three 10 ml blood samples: one sample immediately before the exposure; one sample 10 min after the exposure ended; and one sample 30 min ( for shower and tub exposure ) or 1 h ( for ingestion ) after the exposure ended. A sample of the water ( from the tap, from the bath, or from the shower ) was collected for each participant. We analyzed water samples and whole blood for THMs ( bromoform, bromodichloromethane, dibromochloromethane, and chloroform ) using a purge -and -trap / gas chromatography / mass spectrometry method with detection limits in the parts -perquadrillion range. The highest levels of THMs were found in the blood samples from people who took 10 -min showers, whereas the lowest levels were found in the blood samples from people who drank 1 l of water in 10 min. The results from this study indicate that household activities such as bathing and showering are important routes for human exposure to THMs.
Introduction
Chlorine is the most commonly used chemical for disinfecting U.S. water supplies (King and Marrett, 1996 ) ; however, chlorine reacts with organic compounds in the water to produce halogenated hydrocarbon by -products, including trihalomethanes (THMs; e.g., chloroform, bromoform, bromodichloromethane, and dibromochloromethane ) . Exposure to these disinfection by -products (DBPs ) has been associated with cancer, particularly bladder cancer in humans (Cantor et al., 1987 (Cantor et al., , 1998 Zierler et al., 1988; McGeehin et al., 1993; King and Marrett, 1996; Freedman et al., 1997 ) . Because of the human health risk associated with exposure to THMs that results from chlorinating drinking water, the maximum contaminant level (MCL ) for total THMs in finished ( treated ) drinking water is 80 g /l (U.S. EPA, 1998 ).
One difficulty in demonstrating the association between exposure and health outcome is the long latency period for cancer development and the subsequent need to reconstruct water consumption and exposure histories over a long period of time. For example, King and Marrett (1996 ) found that people exposed to THM levels 50 g/ l for 35 years or more had 1.63 times the risk of bladder cancer compared with those exposed for less than 10 years. McGeehin et al. (1993 ) found that the number of years of exposure to chlorinated drinking water was positively associated with risk for bladder cancer. The risk for bladder cancer increased for longer exposure durations (i.e., the odds ratio, OR, was 1.8 for 30 years of exposure) .
Another difficulty in examining the health effects produced by DBPs is determining how to define exposure. Investigators have used water quality indicators such as the source water (ground water vs. surface water ), THM concentrations in the water supply, and the historical chlorine dose for the water supply as indicators of exposure to DBPs. Other studies (e.g., Zierler et al., 1988 ) used length of residence in a community using chlorinated drinking water as the exposure indicator. But these approaches cannot assign individual exposure levels. King and Marrett (1996 ) assessed individual exposures using retrospectively collected data on lifetime water consumption. The difficulties associated with using any of these exposure assessment methods include variability in DBP concentrations in a given water system over time and problems with reconstructing water consumption history. In addition, these methods may not account for all relevant exposure routes. For example, household water use ( e.g., showering, bathing, flushing toilets, or using the dishwasher, washing machine, or faucets) can result in significant indoor air concentrations of volatile organic compounds ( VOCs ), including DBPs and other contaminants ( e.g., trichloroethylene ) ( Andelman, 1985; Giardino et al., 1992; Weisel and Chen, 1994; Wallace, 1997; Howard -Reed et al., 1999 ) , and subsequent VOC exposure through inhalation will vary for different individuals within a household (Wilkes et al., 1996 ) . In addition, DBPs, such as chloroform, can be absorbed through the skin ( Jo et al., 1990a ) .
Biological specimens can be used to determine the dose of DBPs resulting from exposure to tap water by different routes. Both blood and breath analyses should reflect the total internal dose from all routes of exposure ( i.e., inhalation, dermal absorption, and ingestion) and have been used to examine internal doses of VOCs in non -occupationally exposed individuals. For example, Ashley et al. ( 1994 ) found detectable levels of benzene, ethylbenzene, chloroform, and other VOCs in blood samples from non -occupationally exposed subjects selected from the Third National Health and Nutrition Examination Survey. Weisel et al. (1992) and Jo et al. ( 1990a,b ) have utilized breath analysis to examine exposure to chloroform in people who showered with chlorinated tap water. In these studies, although the amount of time between the end of the exposure and sample collection varied among participants, breath samples indicated that exposure to chloroform occurs during showering. Lindstrom et al. ( 1994 ) found that inhalation exposures to benzene ( from gasoline -contaminated water ) during actual showering were approximately two to five times higher than corresponding bathroom exposures ( i.e., benzene concentrations ranged from 758 to 1670 g /m 3 in the shower stall and 366 to 498 g/m 3 in the bathroom during and immediately after the shower ).
To more fully examine the association between exposure to DBPs and cancer, researchers must account for all of the relevant household activities (e.g., bathing, showering, drinking water ) in estimating an individual's lifetime dose of DBPs. In this study, we examined whole blood levels of THMs in individuals exposed by bathing or showering in tap water, or by drinking tap water.
Methods

Study Design and Population
This study was conducted in Atlanta, Georgia, using a consent form and protocol approved by the Institutional Review Board of the Centers for Disease Control and Prevention (CDC ) . We obtained informed consent from 31 adult volunteers ( 20 women, 11 men ) who agreed to participate in one of the following household activities: showering for 10 min with tap water ( n= 11 ), immersing themselves for 10 min in a bathtub filled with tap water (n = 10) , or drinking 1 l of water during a 10 -min time period (n = 10) . For the showering and bathing segments, we asked participants to collect a sample of the water they used and measure with a thermometer the temperature of the water they used. The water flow, which was the same for all participants, was 7.2 l/ min. Automatic ventilation fans were on in the bathrooms at all times during study activities.
Study participants were also requested to provide three 10 ml blood samples associated with the tap water exposure: one sample immediately before the exposure; one sample 10 min after the exposure had ended (the exposure ended when they got out of the bath, turned off the shower, or finished drinking the water ) ; and one sample 30 min (for shower and tub exposure) or 1 h (for ingestion ) following the end of the exposure. Study participants did not drink water, shower, or bathe during the time between drawing of the second and third blood samples. Study participants were not requested to complete a questionnaire.
Data Collection
Blood Samples A certified phlebotomist collected blood samples using Vacutainer1 tubes that had been processed to remove VOC contamination (Cardinali et al., 1995 ] ) levels using a headspace purge-and -trap / gas chromatography /mass spectrometry method with detection limits in the parts -per-quadrillion range. The mass spectrometry portion of the method had been modified from the original VOC analysis procedure (see Ashley et al., 1992 ) to achieve lower detection limits. To increase the sensitivity of the analysis for THMs in blood, we operated the mass spectrometer in selective ion recording (SIR ) mode instead of in full scan. Extraction of VOCs from blood, trapping on Tenax in a glass -lined steel tube, removal of water, and concentration on a liquid nitrogen trap were done with a Tekmar ( Cincinnati, Ohio) 3000 purge-and -trap concentrator with an attached ALS 2016 automated sampler. We separated the analytes with a J&W (Folsom, California ) 30 m DB -624 column, with a 1.8 m film thickness mounted in a Hewlett -Packard ( Avondale, Pennsylvania ) Model 5890 series II gas chromatograph. The effluent from the gas chromatograph was directed through a heated interface into the mass spectrometer ion source. Mass spectral analysis was done with a Micromass (Beverly, Massachusetts ) Ultima high -resolution mass spectrometer that operated at 10,000 resolving power ( 5% valley definition ) in the SIR voltage mode. Masses were calibrated vs. a mixture of perfluorokerosene (low boiling ) with a 50/50 mixture of toluene and benzene. The mass spectrometry analysis, which included methyl tert -butyl ether ( MTBE ) ,was divided into five groups: MTBE /MTBE -d 10 Water Samples To provide a measure of VOC exposure, we collected tap water samples at the time of exposure. The water samples were collected in borosilicate glass vials which contained 125 l of a phosphate buffer /sodium thiosulfate solution. The solution was made using J.T. Baker ( Phillipsburg, NJ ) HPLC grade water and 1.0 M sodium dihydrogen phosphate, 1.0 M sodium hydrogen phosphate and 0.08 M sodium thiosulfate. This solution raised the pH of the tap water to approximately 6.5 and neutralized any free chlorine present in the sample. We examined residual chlorine and pH for all samples.
We analyzed the water samples for THM levels using solid phase microextraction ( SPME ) /gas chromatography / mass spectrometry with method detection limits in the parts -per-trillion range. Extraction of the THMs from the water sample was done using a Supelco ( Bellefonte, PA ) 100 m carboxen/PDMS SPME fiber attached to a Varian ( Walnut Creek, CA ) 8200 automated sampler. THMs were absorbed onto the SPME fiber at room temperature for 10 min and then desorbed into the GC inlet at 2008C for 3 min. We separated the analytes with a Supelco 10 m VOCOL column with a 1.20 m film thickness mounted in a Hewlett -Packard (Avondale, PA ) Model 5890 gas chromatograph. Mass spectral analysis was done with a Hewlett -Packard 5972 mass selective detector. The mass selective detector was operated in the selected ion monitoring mode with dwell times varying from 50 to 100 ms per ion for a total scan rate of 1.69 cycles / s. We also determined water concentrations using isotope dilution mass spectrometry methods.
Data Analysis
We compared the mean concentrations of THMs in the blood of people exposed to tap water, both before and after exposure, and by the three different routes, using Statistical Analysis System software (SAS Institute, Cary, North Carolina) .
Results and discussion
The whole blood levels of bromodichloromethane, dibromochloromethane, and chloroform are presented in Figures  1 ±3, respectively. There were measurable levels of THMs in all the water and whole blood samples that were analyzed. The highest median levels of THMs were found in the blood samples from people who took 10-min showers, whereas the lowest median levels were found in the blood samples from people who drank 1 l of water in 10 min. For example, the median levels of bromodichloromethane in blood samples from people who took a shower were 3.3 pg/ ml (baseline ) , 19.4 pg /ml ( 10 min after exposure ended) , and 10.3 pg/ ml ( 30 min after exposure ended ). The median levels of bromodichloromethane in blood samples from people who took a bath were 2.3 pg /ml (baseline ), 17.0 pg /ml ( 10 min after exposure ended ), and 9.9 pg /ml (30 min after exposure ended ). For those who drank 1 l of water, the median levels of bromodichloromethane in the blood samples were 2.6 pg/ ml (baseline ) , 3.8 pg /ml (10 Figure 1 . Bromodichloromethane levels ( pg / ml whole blood ) in the blood of study participants who bathed or showered in, or drank 1 liter of, tap water and provided blood samples before the exposure ( T = 0 ) , 10 min after the exposure ended ( T = 10 ) , and 30 ( for bathing or showering ) or 60 ( for drinking ) min after exposure ended. The mean concentration of bromodichloromethane in tap water was 6 g / l. For the box plots: the box extents indicate the 25th and 75th percentiles of the column, the line inside the box marks the value of the 50th percentile, capped bars indicate the 10th and 90th percentiles, and circles mark the 5th and 95th percentiles. *Significantly different from baseline, P < 0.01; **Significantly different from baseline, P < 0.001.
min after drinking all the water ), and 2.8 pg /ml (1 h after drinking the water ) . We obtained similar relative findings for dibromochloromethane and chloroform.
The highest blood levels of each THM were found in the samples collected 10 min after exposure ended. By the second post -exposure time (30 min for showering or bathing; 60 min for drinking water ), the blood levels had decreased significantly, but were still higher than baseline levels. Bromoform was not found above the detection limit in any blood or water samples in this study.
We found a dramatic difference between the whole blood levels resulting from exposure by ingestion and those resulting from showering and bathing (a combination of inhalation, dermal contact, and possibly ingestion ) . The blood levels of THMs increased by an average of 16.1 pg / ml in subjects who showered, an average of 14.7 pg /ml in subjects who bathed, and an average of 1.2 pg /ml in subjects who drank 1 l of water. Thus, drinking 1 l of water increased blood levels by less than 10% of the increase resulting from bathing or showering for 10 min. The increases in blood THMs from showering or bathing were significantly greater than the increases from drinking 1 l of water ( P <0.001 for bromodichloromethane and dibromochloromethane; P= 0.017 for chloroform ).
In addition to finding the differences in blood THM levels among the exposure groups, we found that the increases in blood THM levels in people who showered or bathed fell roughly into two groups; one group had a lower range of increases in blood levels while the other group was clustered at a higher blood level of bromodichloromethane after showering or bathing (Figure 4 ) . The mean increases in bromodichloromethane blood levels for the two clusters observed after participants bathed (8.2, standard deviation [SD] =2.97, n =5 for the lower cluster; and 21.2 pg /ml; SD = 4.26, n = 5 for the higher cluster ) or showered (12.1 pg /ml, SD = 1.87, n =6 for the lower cluster; and 21.0 pg / ml, SD =2.07, n = 5 for the higher cluster ) were significantly different ( P <0.001) . The same individuals who had higher increases of bromodichloromethane also had higher increases of dibromochloromethane and chloroform after these exposures. The mean increases for total THMs for the clusters were also statistically significantly different for the groups that bathed (P=0.05 ) or showered (P < 0.01) . . Dibromochloromethane levels ( pg / ml whole blood ) in the blood of study participants who bathed or showered in, or drank 1 liter of, tap water and provided blood samples before the exposure ( T = 0 ) , 10 min after the exposure ended ( T = 10 ) , and 30 ( for bathing or showering ) or 60 ( for drinking ) min after exposure ended. The mean concentration of dibromochloromethane in tap water was 1.1 g / l. For the box plots: the box extents indicate the 25th and 75th percentiles of the column, the line inside the box marks the value of the 50th percentile, capped bars indicate the 10th and 90th percentiles, and circles mark the 5th and 95th percentiles. *Significantly different from baseline, P < 0.01; **Significantly different from baseline, P < 0.001. Figure 4. Increase in bromodichloromethane levels ( pg / ml whole blood; ppt ) in the blood of study participants 10 min after they bathed or showered for 10 min in tap water. The mean concentration of bromodichloromethane in tap water was 6.0 g / l.
The reason why the data fall into two groups is not clear. The clustering could not be explained by sex (we did not collect information about race or smoking status). It is possible that this clustering is the result of individual variations in the ability to metabolize THMs. For example, brominated THMs are substrates for glutathione S -transferase (GST ) -theta -mediated glutathione conjugation reactions ( Landi et al., 1999 ) . This enzyme is polymorphically expressed in people, and individuals who have the active enzyme would have higher blood levels of the metabolites ( and lower levels of the parent compound ) than individuals who do not possess the active enzyme.
The observed pattern in the increase in blood THM levels could also be associated with the fitness of individual participants. People who inhale larger volumes of air would inhale higher doses of volatilized THMs, and this would be reflected in their blood THM levels; however, we would expect these differences to be on a continuous scale rather than falling into two groups. Evaluation of these differences requires further experiments that include specific evaluation of enzyme activity and personal cardiorespiratory parameters.
Of particular interest were the measurable levels of THMs in the baseline (pre -exposure) blood samples for all study participants. The half -life of VOCs (such as THMs ) in human blood is typically very short (less than 1 h) ( Ashley and Prah, 1997 ) , suggesting that pre -exposure levels would be very low if not undetectable. However, there is evidence that VOCs are stored in multiple sites within the body and that, with repeated exposure, these compounds may bioaccumulate (Ashley and Prah, 1997 ) . Apart from exposure to heavily chlorinated water in swimming pools or hot tubs, the most common source of THM exposure is from household water. The detection of THMs in the blood of people even before they participated in the experimental exposures suggests either that there was a recent exposure before participating in the study or that these compounds have bioaccumulated over time from repeated exposure to tap water.
The concentration of contaminants in drinking water varies over time and is dependent on the characteristics of the source water, types of treatment methods, characteristics of the distribution system, and ways the water is used. To provide a measure of VOC exposure, we collected samples of the tap water used by each study participant. The analyses of the drinking water samples are presented in Table 1 . Drinking water sources in the Atlanta area contain very little bromide, thus bromoform was not detected in any of the samples. Measurable levels of bromodichloromethane, dibromochloromethane, and chloroform were found in all of the water samples tested. The mean total THM level in the water used for exposure in this study was 35 g /l. The concentrations of THMs in these samples were well below the current EPA standard for total THMs in drinking water (80 g/ l). In fact, these levels are below the Stage 2 proposal of 40 g/ l. Despite the fact that the water contained relatively low levels of THMs, this exposure resulted in significant increases in internal dose levels of these compounds in the subjects. The determination of detectable levels of THMs in people's blood even before they participated in study activities is important in considering the human health risk from exposure to THMs and other volatile drinking water contaminants. Repeated exposures to THMs from various household activities could increase the body burden of THMs and potentially increase the risk for adverse health effects.
Exposure to THMs from drinking water can occur by inhalation, ingestion, and dermal absorption, and the tissue distributions of THMs vary with the route of exposure. In our study, people who drank water consumed an average of 35 g total trihalomethanes ( TTHMs ). If this dose was absorbed entirely by the blood (assuming an average blood volume of 5 l), we would expect to see blood levels of approximately 7 ng/ ml TTHM. We actually found an average of 29 pg/ ml TTHM in this group 10 min after they finished drinking the water. Thus, 10 min after drinking 1 l of water, most of the ingested dose is excreted or metabolized rather than absorbed into the blood. By contrast, exposure to volatilized THMs by inhalation and dermal absorption resulted in a more direct distribution to the blood and higher blood levels. (i.e, 10 min after showering or bathing, study participants had 152 pg/ ml TTHM or 181 pg /ml TTHM, respectively, in their blood ).
The differences in blood THM levels following different types of household exposures would also be affected by the water temperature at the time of exposure. Weisel and Chen (1994) reported that calculated THM exposure levels were 50% higher when using THM concentrations in heated water than when using THM concentrations in cold water. In our study, THM concentrations were higher in bath or shower water than in cold tap water ( see Table 1 ) , and blood THM levels in people who showered or bathed were significantly higher than the blood levels of those who drank water. However, the specific temperature of the water used for bathing or showering did not appear to have an important impact on subsequent blood THM levels. The Household exposures to drinking water disinfection by-products Backer et al.
average temperature of the water used for showering was 378C ( range 34 ±438C ) and the average temperature of the water used for bathing was 388C ( range 36 ± 448C). The most consistent human health effect associated with exposure to THMs is bladder cancer. The studies done by Cantor et al. ( 1987 Cantor et al. ( , 1998 , Zierler et al. (1988 ) , McGeehin et al. (1993 ) , King and Marrett (1996 ) and Freedman et al. ( 1997 ) produced strikingly similar results. However, despite the consistency, the reported risk for bladder cancer from lifetime exposure to high levels of THMs reported by these studies was nearly universally less than 2.0. Exposure was typically assessed by examining historical water treatment plant records or by reconstructing a person's water consumption history. In our study, we found that the dermal and inhalation exposures associated with showering and bathing resulted in much higher blood levels of THMs than drinking 1 l of water. If blood THM levels are a risk factor for subsequent human health effects, such as bladder cancer, then water consumption may not be the only important route of exposure. Accounting for an individual's participation in household activities involving tap water, as well as his tap water consumption, may allow a more accurate individual exposure assessment. Our study has demonstrated that public health messages indicating that an individual can significantly reduce his or her exposure to THMs by not drinking tap water may lead to a false sense of security regarding the risk for adverse health outcomes associated with THM exposure.
